Atom | BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

Funder: National Institutes of Health

Due Dates: January 28, 2025 (New/Renewal/Resubmission/Revision) | September 28, 2026 (New/Renewal/Resubmission/Revision)

Funding Amounts: NIH anticipates $10M/year for 5–7 awards; budgets rarely exceed $1.5M direct costs/year; project period up to 5 years.

Summary: Supports first-in-human or early-stage clinical studies of next-generation devices for recording and/or stimulation in the human CNS to advance device development for CNS disorders.

Key Information: Only Significant Risk (SR) studies requiring FDA IDE are eligible; non-clinical testing must be complete before application.

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

Sign in to see full grant listing